{
    "2021-02-22": [
        [
            {
                "time": "2021-01-01",
                "original_text": "复星医药：积极推进新型冠状病毒mRNA疫苗上市进展",
                "features": {
                    "keywords": [
                        "复星医药",
                        "新型冠状病毒",
                        "mRNA疫苗",
                        "上市进展"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-01",
                "original_text": "复星医药(02196)聘请中金公司担任非公开发行A股股票工作的保荐机构",
                "features": {
                    "keywords": [
                        "复星医药",
                        "中金公司",
                        "非公开发行",
                        "A股股票",
                        "保荐机构"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-01-01",
                "original_text": "复星医药(02196.HK)拟变更保荐机构及保荐代表人",
                "features": {
                    "keywords": [
                        "复星医药",
                        "保荐机构",
                        "变更",
                        "保荐代表人"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "制药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-01-01",
                "original_text": "复星医药(02196.HK)参与设立的投资基金完成私募投资基金备案",
                "features": {
                    "keywords": [
                        "复星医药",
                        "投资基金",
                        "私募投资基金",
                        "备案"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "投资"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-01-01",
                "original_text": "【异动股】复星医药(02196-HK)跌3.22%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "异动股",
                        "下跌",
                        "3.22%"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-01-01",
                "original_text": "2021年，创新转型将成为传统药企发展重点",
                "features": {
                    "keywords": [
                        "2021年",
                        "创新转型",
                        "传统药企",
                        "发展重点"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制药",
                        "创新"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}